Clincosm LogoSign in Get a demo

Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital

Sponsor
CHU de Reims (Other)
Overall Status
Completed
CT.gov ID
NCT05142748
Collaborator
(none)
132
Enrollment
1
Location
15
Actual Duration (Months)
8.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The investigators aimed to assess the epidemiology, management, and outcomes of community-acquired pneumonia in a kidney transplant recipients' cohort and identify prognosis factors associated with in-hospital complications. The investigatorsintend to identify each stay by a national database. Then they will be consulted by 2 clinicians to assert CAP clinical definition. After that radiographic evidence will be reviewed to validate CAP diagnoses. Then clinical data are collected in each center.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    132 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital
    Actual Study Start Date :
    Sep 1, 2019
    Actual Primary Completion Date :
    Nov 30, 2020
    Actual Study Completion Date :
    Nov 30, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Complication [Day 30]

      Death

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • kidney transplant recipients

    • at least 18 years

    • admitted to hospital for CAP. Non-inclusion criteria were:

    Exclusion Criteria:

    • incomplete CAP definition

    • hospital-acquired pneumonia

    • another diagnosis explaining the symptoms

    • patients with non-functional kidney graft

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Chu Reims Reims France 51092

    Sponsors and Collaborators

    • CHU de Reims

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    CHU de Reims
    ClinicalTrials.gov Identifier:
    NCT05142748
    Other Study ID Numbers:
    • 2021Ao001
    First Posted:
    Dec 3, 2021
    Last Update Posted:
    Dec 3, 2021
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Infections
    Communicable Diseases
    Pneumonia

    Study Results

    No Results Posted as of Dec 3, 2021